Allergy Vaccinations Reduce Children’s Health Care Costs By One-Third

Jim Marino — Wed, 13 Jan 2010 08:38:48 +0000

Allergy immunotherapy, generally referred to as allergy vaccinations or shots, reduce total health care costs in children with allergic rhinitis by one-third, and prescription costs by 16 percent, according to a study published this month in Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI). Allergic rhinitis is the third most common chronic disease in children, affecting up to 40 percent of the population.

For the full article, Click Here

Grazax Phase III pediatric trial encouraging

Jim Marino — Tue, 06 May 2008 16:12:59 +0000

Grazax, the allergy immunotherapy developed by Schering-Plough and ALK-Abello, showed a 28% reduction in hay fever symptoms during its Phase III pediatric trial. According to Denmark-based ALK-Abello, the therapy led to a 64% reduction in the combined asthma symptom score as well. The previous European trial of Grazax displayed positive clinical effect. A Grazax pediatric registration application is currently under review in Europe.

Photo by marcbenton

Immunology Product Guide » allergy immunotherapy

Allergy Vaccinations Reduce Children’s Health Care Costs By One-Third

Grazax Phase III pediatric trial encouraging